Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent trends in allogeneic bone marrow transplantation.

E Gluckman1

  • 1Bone Marrow Transplantation Unit, Hopital Saint Louis, Paris, France.

Clinical Transplants
|January 1, 1989
PubMed
Summary

Allogeneic bone marrow transplants show variable success rates for leukemia and chronic myeloid leukemia. Ongoing research aims to improve outcomes by refining donor matching and reducing transplant complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.

Bone marrow transplantation·2007
Same author

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation.

Bone marrow transplantation·2007
Same author

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.

Bone marrow transplantation·2007
Same author

[Clinical research at the European LeukemiaNet].

Deutsche medizinische Wochenschrift (1946)·2006

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Immunology

Background:

  • Allogeneic bone marrow transplantation (BMT) is a recognized treatment for various hematologic malignancies.
  • European and International registries provide extensive data on BMT indications and outcomes.

Purpose of the Study:

  • To summarize current indications and outcomes of allogeneic bone marrow transplantation.
  • To review risk factors influencing transplant success.
  • To highlight ongoing research aimed at improving BMT efficacy and safety.

Main Methods:

  • Analysis of data from European and International bone marrow transplantation registries.
  • Review of established risk factors affecting transplant outcomes.
  • Summary of current research strategies to reduce relapse and graft-versus-host disease.

Main Results:

  • Disease-free survival (DFS) varies by leukemia type and remission status: 45% for acute nonlymphoblastic leukemia in first CR, 60% for ALL in first CR, 40% for ALL in second CR, and 60% for CML in chronic phase.
  • Risk factors including age, donor match, disease status, CMV serology, and GvHD significantly impact outcomes.
  • Unrelated HLA-matched donor transplants show approximately 40% DFS, while mismatched related transplants yield disappointing results unless there is only one HLA mismatch.

Conclusions:

  • Allogeneic bone marrow transplantation outcomes are influenced by disease-specific factors and patient/donor characteristics.
  • Strategies to reduce relapse risk, such as intensified conditioning and leveraging graft-versus-leukemia effects, are under investigation.
  • Advances in donor selection, including unrelated donors and cryopreserved cord blood cells, along with methods to mitigate GvHD and improve engraftment, hold promise for enhancing BMT efficacy, particularly in pediatric cases.

Related Experiment Videos